RecruitingNot ApplicableNCT07278882

Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL

A Randomized Controlled Trial of Mobile Technology-assisted Outpatient Maintenance Therapy in Children With Acute Lymphoblastic Leukaemia (ALL)

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Enrollment

200 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Pediatric Acute Leukemia

Summary

To assess the efficacy of using mobile technology to improve the percentage of time wherein drug dosing is within the target range

Eligibility

Max Age: 16 Years

Inclusion Criteria3

\) \< 16 years old at diagnosis;
\) having demonstrated ≥ 3 months of \> 90% compliance with using a mobile app to log in records of daily medication and weekly blood test results;
\) patient or legal guardian provides informed consent

Exclusion Criteria1

None

Interventions

BEHAVIORALHealth monitoring & reminders for a mobile-phone portal for scheduling a telemedicine clinic visit and receive periodic model-phone messages instructing follow-up blood testing and dose adjustment.

Subjects classified as 'Orange Alert' receive mobile-phone alert messages that instruct them to self-adjust dose of oral medication. Subjects classified as 'Red Alert' are directed to a mobile-phone portal for scheduling a telemedicine clinic visit and receive periodic model-phone messages instructing follow-up blood testing and dose adjustment.

Locations(1)

Institute of Hematology & Blood Diseases Hospital

Tianjin, Tianjin Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07278882